• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺巢鼠海马中多巴胺受体刺激的电生理效应

Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.

作者信息

Bijak M, Danek L, Smiałowski A

机构信息

Institute of Pharmacology, Polish Academy of Sciences, Kraków.

出版信息

Pol J Pharmacol Pharm. 1988 Sep-Oct;40(5):535-41.

PMID:2908137
Abstract

The effect of dopamine receptor agonists on the spontaneous bioelectrical activity of CA1 layer neurons in the hippocampal slice preparation from the Acomys and rat has been studied. The selective D1 receptor agonist SKF 38393 diminished the neuronal firing rate while the selective D2 receptor agonist LY 171555 (quinpirole) evoked an excitatory reaction, however, a great proportion of hippocampal neurons remained unresponsive to SKF 38393 and LY 171555. Both dopamine and apomorphine elicited mainly an increase in the neuronal discharge rate, the effect of the former having been antagonized by sulpiride. The present data reveal that the action of dopamine agonists on the hippocampal neurons of the Acomys generally resembles their activity on the rat hippocampal cells, however, the potency of dopamine and apomorphine in evoking the excitatory reaction is higher in the Acomys.

摘要

研究了多巴胺受体激动剂对来自非洲刺毛鼠和大鼠的海马脑片制备中CA1层神经元自发生物电活动的影响。选择性D1受体激动剂SKF 38393降低了神经元放电频率,而选择性D2受体激动剂LY 171555(喹吡罗)诱发了兴奋反应,然而,很大一部分海马神经元对SKF 38393和LY 171555无反应。多巴胺和阿扑吗啡均主要引起神经元放电频率增加,前者的作用被舒必利拮抗。目前的数据表明,多巴胺激动剂对非洲刺毛鼠海马神经元的作用总体上类似于它们对大鼠海马细胞的活性,然而,多巴胺和阿扑吗啡诱发兴奋反应的效力在非洲刺毛鼠中更高。

相似文献

1
Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.刺巢鼠海马中多巴胺受体刺激的电生理效应
Pol J Pharmacol Pharm. 1988 Sep-Oct;40(5):535-41.
2
Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.D-1激动剂SKF 38393对黑质多巴胺能神经元紧张性活动影响的神经生理学研究
Synapse. 1987;1(5):411-6. doi: 10.1002/syn.890010505.
3
Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.大鼠内侧前额叶皮质中介导对多巴胺电生理反应的受体的药理学特性:一项微量离子电泳研究。
J Pharmacol Exp Ther. 1989 Mar;248(3):1323-33.
4
SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.司可巴比妥38393改变黑质纹状体多巴胺能神经元中依赖速率的D2介导的抑制作用,但不改变中脑伏隔核多巴胺能神经元的该抑制作用。
Synapse. 1988;2(4):416-23. doi: 10.1002/syn.890020409.
5
Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
J Pharmacol Exp Ther. 1989 Jun;249(3):790-7.
6
Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.黑质纹状体损伤改变大鼠苍白球对选择性和非选择性D-1和D-2多巴胺激动剂的神经生理反应。
Synapse. 1990;5(2):83-93. doi: 10.1002/syn.890050202.
7
Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.在行为学大鼠中通过脑透析研究多巴胺受体激动剂的药理学特性。
J Pharmacol Exp Ther. 1988 Apr;245(1):257-64.
8
Prolonged treatment with antidepressant drugs increases the excitatory effect of quinpirole in hippocampal slices.长期使用抗抑郁药物治疗会增强喹吡罗对海马切片的兴奋作用。
Pol J Pharmacol. 1993 Jul-Aug;45(4):381-90.
9
Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.不同年龄经6-羟基多巴胺处理的大鼠中多巴胺激动剂诱导的运动活性:新生期损伤大鼠中D-1多巴胺受体的功能超敏反应
J Pharmacol Exp Ther. 1985 Aug;234(2):447-55.
10
Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.D1和D2多巴胺激动剂对大鼠大脑新皮质和海马脑电图活动的影响:瑞米唑效应的调节
Methods Find Exp Clin Pharmacol. 1993 Oct;15(8):515-25.